Erythema Gyratum Repens Responding to Cetirizine Hydrochloride

Miyagawa, Fumi; Danno, Kiichiro; Uehara, Masami

doi:10.1111/j.1346-8138.2002.tb00211.x

Cited by 6 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This patient responded poorly to topical steroid and oxatomide, but improved dramatically after cetirizine was administered. The antieosinophil effect of cetirizine may explain the good response in this patient [ 55 ].…”

Section: Clinical Applications In Dermatologic Diseasesmentioning

confidence: 99%

Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review

Hsieh

Tsai

2021

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

H-1 antihistamines are commonly used in dermatological practice for itch and urticaria control. The widespread expression of H-1 receptor on different cells in the skin and various biologic functions of H-1 antihistamines indicate the possible treatment potentials of H-1 antihistamines in dermatology. A literature search was performed on PubMed and Embase, targeting articles reporting use of antihistamine for purposes other than itch and urticaria control in dermatological practice. Several off-label usages of antihistamines were identified, including alopecia, acne, Darier disease, eosinophilic dermatoses, paraneoplastic dermatoses, psoriasis, lichen nitidus, radiation dermatitis, skin dysesthesia, and cutaneous malignancies. Additional benefits were observed when H-1 antihistamines were used either alone or in combination with other therapeutic modalities. Although various novel uses of H-1 antihistamines have been uncovered, the evidence level of most included studies is weak. Further randomized control trials are warranted to better evaluate the efficacy and dosage of H-1 antihistamine for dermatological disorders.

show abstract

Section: Clinical Applications In Dermatologic Diseasesmentioning

confidence: 99%

Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review

Hsieh

Tsai

2021

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

show abstract

“…Among the one hundred previously reported and analyzed by us cases of TABE, the death of 68 patients was reported ( 4 , 7 , 8 , 10 – 14 , 16 – 22 , 24 – 28 , 30 , 32 , 34 – 37 , 39 , 44 , 46 – 51 , 53 – 60 , 65 , 67 – 69 , 71 , 72 , 74 – 76 , 82 – 88 , 94 – 96 ). About 90% of the deaths occurred within one year after the diagnosis of paraneoplastic hypereosinophilia.…”

Section: Discussionmentioning

confidence: 99%

Hypereosinophilia in Solid Tumors—Case Report and Clinical Review

2021

View full text Add to dashboard Cite

BackgroundRenal cell cancer may cause various paraneoplastic syndromes; however, paraneoplastic hypereosinophilia occurs exceedingly rare. Thus far, only two cases of clear cell renal cell carcinoma (CCRCC) associated with hypereosinophilia have been reported. In this paper, we present a case of paraneoplastic hypereosinophilia associated with renal cell carcinoma and a review of the reported cases of hypereosinophilia in solid tumors.MethodsThe review is based on an electronic literature search performed in the PubMed database in September 2020 with the following key terms: eosinophilia & neoplasm; eosinophilia & cancer; eosinophilia & paraneoplastic syndrome. Papers were included based on screening the titles and/or abstracts. We also included the case of our patient in the analysis.Case presentationA 68-year-old Caucasian female patient with recurrent CCRCC was admitted to our Clinic for exacerbating dyspnea and chest and right upper abdominal pain, accompanied by confusion. Preliminary blood tests showed an increased white blood cell count of 40,770/μl, and an increased eosinophil count of 6,530/μl indicating eosinophilia. Several tests were carried out to rule out the noncancer causes of hypereosinophilia. The temporal appearance of eosinophilia and the recurrence of CCRCC without any other apparent potential causes led to the diagnosis of paraneoplastic hypereosinophilia. Despite treating with high doses of corticosteroids, only a transient decrement in eosinophil count was observed along with further deterioration of the patient’s condition. The patient succumbed to the disease 6 months following the tumor surgery and 2 months after the diagnosis of hypereosinophilia and tumor recurrence.ConclusionOur observations are in agreement with the majority of reports showing that the occurrence of eosinophilia following tumor resection may indicate a poor prognosis, tumor recurrence, and rapid disease progression.

show abstract

Erythema and Urticaria

2011

Andrews' Diseases of the Skin

View full text Add to dashboard Cite

Erythema Gyratum Repens Responding to Cetirizine Hydrochloride

Cited by 6 publications

References 17 publications

Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review

Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review

Hypereosinophilia in Solid Tumors—Case Report and Clinical Review

Erythema and Urticaria

Contact Info

Product

Resources

About